Picture of the month

Archives of Pediatrics and Adolescent Medicine

Volumn 160, Issue 11, 2006, Pages 1177-1179

  Burnham, Jon M ^a   Kreiger, Portia A ^a   Paessler, Michele ^a   Kersun, Leslie S ^a   Cron, Randy Q ^a  

^a CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LACTATE DEHYDROGENASE; URIC ACID; VASOPRESSIN;

ANAMNESIS; ARTICLE; BONE MARROW BIOPSY; CASE REPORT; CLINICAL FEATURE; EPSTEIN BARR VIRUS; HOSPITAL ADMISSION; HUMAN; HUMAN TISSUE; INAPPROPRIATE VASOPRESSIN SECRETION; LACTATE DEHYDROGENASE BLOOD LEVEL; LYMPHOCYTIC INFILTRATION; MALE; PRIORITY JOURNAL; SCHOOL CHILD; SEPSIS; SEROLOGY; SKIN BIOPSY; URIC ACID BLOOD LEVEL; VASOPRESSIN BLOOD LEVEL; VIRUS INFECTION; CHILD; FATALITY; HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS; LARGE CELL LYMPHOMA; PATHOLOGY;

CHILD; FATAL OUTCOME; HUMANS; LYMPHOHISTIOCYTOSIS, HEMOPHAGOCYTIC; LYMPHOMA, LARGE-CELL, KI-1; MALE;

EID: 33750844578     PISSN: 10724710     EISSN: 10724710     Source Type: Journal    
DOI: 10.1001/archpedi.160.11.1177     Document Type: Article

References (14)

1. Grom AA. Natural killer cell dysfunction: a common pathway in systemic-onset juvenile rheumatoid arthritis, macrophage activation syndrome, and hemophagocytic lymphohistiocytosis? Arthritis Rheum. 2004;50:689-698.
2. Yung A, Snow J, Jarrett P. Subcutaneous panniculitic T-cell lymphoma and cytophagic histiocytic panniculitis. Australas J Dermatol. 2001;42:183-187.
3. Chen GS, Chang YF, Chang MC, Tsan KW. Response of Epstein-Barr virus-associated Ki-1+ anaplastic large cell lymphoma to 13-cis retinoic acid and interferon alpha. J Formos Med Assoc. 1998;97:420-424.
4. Harris NL, Jaffe ES, Diebold J, et al. World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting - Airlie House, Virginia, November 1997. J Clin Oncol. 1999;17:3835-3849.
5. Tomaszewski MM, Moad JC, Lupton GP. Primary cutaneous Ki-1(CD30) positive anaplastic large cell lymphoma in childhood. J Am Acad Dermatol. 1999;40:857-861.
6. Hinshaw M, Trowers AB, Kodish E, Kuerbitz S, Shurin S, Wood GS. Three children with CD30 cutaneous anaplastic large cell lymphomas bearing the t(2;5) (p23;q35) translocation. Pediatr Dermatol. 2004;21:212-217.
7. Janka GE, Schneider EM. Modern management of children with haemophagocytic lymphohistiocytosis. Br J Haematol. 2004;124:4-14.
8. Fisman DN. Hemophagocytic syndromes and infection. Emerg Infect Dis. 2000;6:601-608.
9. Larroche C, Mouthon L. Pathogenesis of hemophagocytic syndrome (HPS). Autoimmun Rev. 2004;3:69-75.
10. Seidemann K, Tiemann M, Schrappe M, et al. Short-pulse B-non-Hodgkin lymphoma-type chemotherapy is efficacious treatment for pediatric anaplastic large cell lymphoma: a report of the Berlin-Frankfurt-Munster Group Trial NHL-BFM 90. Blood. 2001;97:3699-3706.
11. Zinzani PL, Martelli M, Magagnoli M, et al. Anaplastic large cell lymphoma Hodgkin's-like: a randomized trial of ABVD versus MACOP-B with and without radiation therapy. Blood. 1998;92:790-794.
12. Brugieres L, Deley MC, Pacquement H, et al. CD30(+) anaplastic large-cell lymphoma in children: analysis of 82 patients enrolled in two consecutive studies of the French Society of Pediatric Oncology. Blood. 1998;92:3591-3598.
13. Kobrinsky NL, Sposto R, Shah NR, et al. Outcomes of treatment of children and adolescents with recurrent non-Hodgkin's lymphoma and Hodgkin's disease with dexamethasone, etoposide, cisplatin, cytarabine, and l-asparaginase, maintenance chemotherapy, and transplantation: Children's Cancer Group Study CCG-5912. J Clin Oncol. 2001;19:2390-2396.
14. Sandlund JT, Downing JR, Crist WM. Non-Hodgkin's lymphoma in childhood. N Engl J Med. 1996;334:1238-1248.